Oportuzumab monatox is an experimental anti-cancer medication. Chemically, oportuzumab is a single chain variable fragment of a monoclonal antibody which...
3 KB (225 words) - 23:43, 17 July 2024
Moxetumomab pasudotox Naxitamab Necitumumab Nivolumab Olaratumab Oportuzumab monatox Pembrolizumab Polatuzumab vedotin Prolgolimab Ramucirumab Retifanlimab...
12 KB (794 words) - 03:30, 2 September 2024
Moxetumomab pasudotox Naxitamab Necitumumab Nivolumab Olaratumab Oportuzumab monatox Pembrolizumab Polatuzumab vedotin Prolgolimab Ramucirumab Retifanlimab...
12 KB (758 words) - 23:46, 14 March 2024
(protein) (VSIR) Opicinumab mab human LINGO-1 multiple sclerosis Oportuzumab monatox Vicinium scFv humanized EpCAM bladder cancer Oregovomab OvaRex mab...
136 KB (4,020 words) - 07:14, 15 August 2024
L01FX14 Polatuzumab vedotin L01FX15 Belantamab mafodotin L01FX16 Oportuzumab monatox L01FX17 Sacituzumab govitecan L01FX18 Amivantamab L01FX19 Sabatolimab...
12 KB (877 words) - 15:36, 25 January 2024
Obinutuzumab Ocaratuzumab§ Odronextamab Otlertuzumab§ Onartuzumab§ Oportuzumab monatox† Parsatuzumab§ Pertuzumab Pinatuzumab vedotin§ Polatuzumab vedotin...
5 KB (368 words) - 15:29, 21 August 2024
Obinutuzumab Ocaratuzumab§ Odronextamab Otlertuzumab§ Onartuzumab§ Oportuzumab monatox† Parsatuzumab§ Pertuzumab Pinatuzumab vedotin§ Polatuzumab vedotin...
3 KB (129 words) - 01:04, 19 July 2023
Obinutuzumab Ocaratuzumab§ Odronextamab Otlertuzumab§ Onartuzumab§ Oportuzumab monatox† Parsatuzumab§ Pertuzumab Pinatuzumab vedotin§ Polatuzumab vedotin...
4 KB (241 words) - 13:42, 14 July 2024